mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
PD173074 |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.044 |
0.2 |
mRNA |
etoposide |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.067 |
0.2 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.039 |
0.2 |